Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE) · FederalPipeline
Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)
Solicitation from National Institutes of Health, solicitation ARPA-H-SOL-25-122. Responses due Feb 5, 2026. NAICS 541714, No Set aside used. Listed on SAM.gov.